Patient Access
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."
The funds will help expand the company's deployment of its in-home kidney and polychronic care delivery model and its clinical services.
The Oregon Health Authority said the deal is not likely to greatly reduce access to affordable care in the state, but it placed some conditions on its approval.
Spero Health will widen its use of Pear's reSET and reSET-O prescription digital therapeutics from 14 clinics in Kentucky to 99 locations in five other states.
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
![[Left-Right] Travis Seet, CFO, and Dr Chin Pak Lin, CEO, Asian Healthcare Specialists; Lim Wai Mun, CEO and founder, and Edwin Basuki, CFO, Doctor Anywhere Credit: Doctor Anywhere](/sites/mhn/files/styles/230x130/public/2025-07/Photo_Doctor%2520Anywhere%2520acquires%2520Singapore-listed%2520Asian%2520Healthcare%2520Specialists%252C%2520secures%2520additional%2520US%252438.8%2520million%2520funding.jpg?itok=BMyCZa_X)
The company seeks to meet the rising demand for specialised care across Southeast Asia.
The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.
MediOrbis will incorporate Kahun's AI tool into its platform to provide clinical insights to healthcare providers based on patients’ intake information.
The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.
However, these tools are not yet able to provide personalised advice.